Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hallucinogens”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Not applicableLooking for participantsNCT06581263
What this trial is testing

Psychedelic Virtual Reality

Who this might be right for
Psychedelic ExperiencesVirtual RealityHealthy Volunteer
Yale University 15
Not applicableStudy completedNCT06372197
What this trial is testing

Low-Income Group Psilocybin Assisted Therapy for Depression

Who this might be right for
Depression
Matthew Hicks 20
Testing effectiveness (Phase 2)Looking for participantsNCT06471959
What this trial is testing

Psychedelic-assisted Group Program for First Responders

Who this might be right for
PsilocybinPsychotherapy, Group
Empower Research Inc 32
Early research (Phase 1)Active Not RecruitingNCT05322954
What this trial is testing

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

Who this might be right for
Methamphetamine Use DisorderSubstance-Related DisordersChemically-Induced Disorders+2 more
University of Wisconsin, Madison 12
Early research (Phase 1)Study completedNCT04842045
What this trial is testing

Pilot RECAP Study in Healthy Volunteers

Who this might be right for
Psychedelic ExperiencesAmnesia
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)UnknownNCT04593563
What this trial is testing

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Maryland Oncology Hematology, PA 30
Testing effectiveness (Phase 2)Looking for participantsNCT03781128
What this trial is testing

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

Who this might be right for
Cluster Headache
University Hospital, Basel, Switzerland 30
Not applicableStudy completedNCT06557239
What this trial is testing

Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy

Who this might be right for
Depression, Anxiety
Tatiana Aboulafia Brakha 10
Early research (Phase 1)Looking for participantsNCT06070649
What this trial is testing

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Who this might be right for
Alcohol Use Disorder (AUD)Alcohol-Related DisordersAlcohol Use
Yale University 63
Not applicableNot Yet RecruitingNCT06529939
What this trial is testing

The Effects of Psilocybin on Shared Experience in Film Processing

Who this might be right for
Disorders of ConsciousnessPsychedelic Experiences
Western University, Canada 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07296094
What this trial is testing

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
Brigham and Women's Hospital 36
Testing effectiveness (Phase 2)Study completedNCT06816667
What this trial is testing

Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety

Who this might be right for
Healthy Volunteers
Biomind Labs Inc. 40
Early research (Phase 1)Study completedNCT01988311
What this trial is testing

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Who this might be right for
PsilocybinHallucinogensPharmacologic Actions+3 more
Johns Hopkins University 10
Early research (Phase 1)Study completedNCT05175430
What this trial is testing

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Study completedNCT04661514
What this trial is testing

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy

Who this might be right for
Anorexia Nervosa
University of California, San Diego 16
Testing effectiveness (Phase 2)Looking for participantsNCT06626139
What this trial is testing

Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers

Who this might be right for
Healthy Participants With Lower-than-average Mental Well-being
Robin Carhart-Harris, PhD, MA 120
Very early researchLooking for participantsNCT06899594
What this trial is testing

Psilocybin for Methamphetamine Addiction

Who this might be right for
Methamphetamine Use Disorder
Kevin Murnane 20
Testing effectiveness (Phase 2)Looking for participantsNCT06538285
What this trial is testing

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Who this might be right for
Methamphetamine Use Disorder
Nicky Mehtani, MD, MPH 12
Early research (Phase 1)WithdrawnNCT05467761
What this trial is testing

Bioavailability Study of Psilocybin in Normal Adults

Who this might be right for
Healthy
University of Wisconsin, Madison
Very early researchWithdrawnNCT05252598
What this trial is testing

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Who this might be right for
Mood DisturbanceMood ChangeSleep Disturbance+7 more
Optimi Health Corporation
Load More Results